Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Improving (18)F-Fluoro-D-Glucose-Positron Emission Tomography/Computed Tomography Imaging in Alzheimer's Disease Studies.

KneĊĦaurek K.

World J Nucl Med. 2015 Sep-Dec;14(3):171-7. doi: 10.4103/1450-1147.163246.

2.

Neuroimaging of Parkinson's disease: Expanding views.

Weingarten CP, Sundman MH, Hickey P, Chen NK.

Neurosci Biobehav Rev. 2015 Dec;59:16-52. doi: 10.1016/j.neubiorev.2015.09.007. Epub 2015 Sep 26. Review.

PMID:
26409344
3.

Qualitative and Quantitative Evaluation of Blob-Based Time-of-Flight PET Image Reconstruction in Hybrid Brain PET/MR Imaging.

Leemans EL, Kotasidis F, Wissmeyer M, Garibotto V, Zaidi H.

Mol Imaging Biol. 2015 Oct;17(5):704-13. doi: 10.1007/s11307-015-0824-x.

4.

Role of nuclear medicine in neuroHIV: PET, SPECT, and beyond.

Sathekge M, McFarren A, Dadachova E.

Nucl Med Commun. 2014 Aug;35(8):792-6. doi: 10.1097/MNM.0000000000000139. Review.

5.

Multimodality molecular imaging of stem cells therapy for stroke.

Chao F, Shen Y, Zhang H, Tian M.

Biomed Res Int. 2013;2013:849819. doi: 10.1155/2013/849819. Epub 2013 Oct 8. Review.

6.

Novel avenues of drug discovery and biomarkers for diabetes mellitus.

Maiese K, Chong ZZ, Shang YC, Hou J.

J Clin Pharmacol. 2011 Feb;51(2):128-52. doi: 10.1177/0091270010362904. Epub 2010 Mar 10. Review.

7.

Fluorine-18 Radiolabeled PET Tracers for Imaging Monoamine Transporters: Dopamine, Serotonin, and Norepinephrine.

Stehouwer JS, Goodman MM.

PET Clin. 2009 Jan;4(1):101-28. doi: 10.1016/j.cpet.2009.05.006.

8.

2-(2'-((Dimethylamino)methyl)-4'-(3-[(18)F]fluoropropoxy)-phenylthio)benzenamine for positron emission tomography imaging of serotonin transporters.

Wang JL, Parhi AK, Oya S, Lieberman B, Kung MP, Kung HF.

Nucl Med Biol. 2008 May;35(4):447-58. doi: 10.1016/j.nucmedbio.2008.02.009.

Items per page

Supplemental Content

Write to the Help Desk